Advertisement

Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncology group study

      Highlights

      • The first prospective surgical study in elderly women with gynecologic cancers
      • Treatment patterns of elderly women with gynecologic malignancies
      • Geriatric assessment scores correlate with post-operative complications

      Abstract

      Introduction

      CC-002 is a prospective cooperative group study conducted by NRG Oncology to evaluate whether a pre-operative GA-GYN score derived from a predictive model utilizing components of an abbreviated geriatric assessment (GA) is associated with major post-operative complications in elderly women with suspected ovarian, fallopian tube, primary peritoneal or advanced stage papillary serous uterine (GYN) carcinoma undergoing primary open cytoreductive surgery.

      Methods

      Patients 70 years or older with suspected advanced gynecologic cancers undergoing evaluation for surgery were eligible. A GA-GYN score was derived from a model utilizing the GA as a pre-operative tool. Patients were followed for six weeks post-operatively or until start of chemotherapy. Post-operative events were recorded either directly as binary occurrence (yes or no) using CTCAE version 4.0.

      Results

      There were 189 eligible patients, 117 patients with primary surgical intervention and 37 patients undergoing interval cytoreduction surgery. The association between higher GA-GYN score and major postoperative complications in patients undergoing primary surgery was not significant (p = 0.1341). In a subgroup analysis of patients with advanced staged malignant disease who underwent primary cytoreductive surgery, there was a trend towards an association with the GA-GYN score and post-operative complications.

      Conclusion

      The pre-operative GA-GYN score derived from a predictive model utilizing components of an abbreviated geriatric assessment was not predictive of major post-operative complications in elderly patients undergoing primary open cytoreductive surgery. However, there was an association between GA-GYN score and post-operative complications in a subgroup of patients with advanced staged malignant disease.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Gynecologic Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Berger N.A.
        • Savvides P.
        • Koroukian S.
        • Kahana E.
        • Deimling G.
        • Rose J.
        • et al.
        Cancer in the elderly.
        Trans. Am. Clin. Climatol. Assoc. 2006; 117: 147-156
        • Howlader N.
        • Noone A.M.
        • Krapcho M.
        • Neyman N.
        • Aminou R.
        • Waldron W.
        • et al.
        SEER Cancer Statistics Review, 1975-2008.
        National Cancer Institute, Bethesda, MD2011 (based on November 2010 SEER data submission, posted to the SEER web site)
        • Hightower R.D.
        • Nguyen H.N.
        • Averette H.E.
        • Hoskins W.
        • Harrison T.
        • Steren A.
        National survey of ovarian carcinoma: patterns of care and related survival for older patients.
        Cancer. 1994; 73: 377-383
        • Eisenher E.L.
        • Tew W.P.
        • Levine D.A.
        • Lichtman S.M.
        • Brown C.L.
        • Aghajanian C.
        • et al.
        Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy.
        Gynecol. Oncol. 2007; 106: 381-387
        • Wright J.D.
        • Herzog T.J.
        • Neugut A.I.
        • Burke W.M.
        • Lu Y.S.
        • Lewin S.N.
        • et al.
        Effect of radical cytoreductive surgery on omission and delay of chemotherapy for advanced stage ovarian cancer.
        Obstet. Gynecol. 2012; 120: 871-881
        • Wright J.
        • Doan T.
        • Mcbride R.
        • Jacobson J.
        • Hershman D.
        Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival.
        Br. J. Cancer. 2008; 98: 1197-1203
        • Vergote I.
        • Trope C.G.
        • Amant F.
        • Kristensen G.B.
        • Ehlen T.
        • Johnson N.
        • et al.
        Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
        N. Engl. J. Med. 2010; 363: 943-953
        • Chi D.S.
        • Musa F.
        • Dao F.
        • Zivanovic O.
        • Sonoda Y.
        • Leitao M.M.
        • et al.
        An analysis of patients with bulky advanced stage ovarian, tubal and peritoneal carcinoma treated with primary debulking surgery during an identical time period as the randomized EORTC-NCIC trial of PDS vs. neoadjuvant chemotherapy.
        Gynecol. Oncol. 2012; 124: 10-14
        • Zighelboim I.
        • Kizer N.
        • Taylor N.P.
        • Case A.S.
        • Gao F.
        • Thaker P.H.
        • et al.
        “Surgical Apgar score” predicts postoperative complications after cytoreduction for advanced ovarian cancer.
        Gynecol. Oncol. 2010; 116: 370-373
        • Aletti G.D.
        • Eisenhauer E.L.
        • Santillian A.
        • Axtell A.
        • Aletti G.
        • Holschneider C.
        • et al.
        Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment.
        Gynecol. Oncol. 2011; 120: 23-28
        • Aletti S.D.
        • Dowdy S.C.
        • Cliby W.A.
        Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer.
        Am. J. Obstet. Gynecol. 2007; 197 (676.e1–7)
        • Hurria A.
        • Cirrincione C.T.
        • Muss H.B.
        • Kornblith A.B.
        • Barry W.
        • Artz A.
        • et al.
        Implementing a geriatric assessment in cooperative group clinical Cancer trials: CALGB 360401.
        J. Clin. Oncol. 2011; 29: 1290-1296
        • Hurria A.
        • Togawa K.
        • Mohile S.
        • Owusu C.
        • Klepin H.
        • Gross C.
        • et al.
        Predicting chemotherapy toxicity in older adults with Cancer: a prospective multicenter study.
        J. Clin. Oncol. 2011; 29: 3457-3465
        • Hurria A.
        • Gupta S.
        • Zauderer M.
        • Zuckerman E.L.
        • Cohen H.J.
        • Muss H.
        • et al.
        Developing a Cancer specific geriatric assessment.
        Cancer. 2005; 104: 1998-2005
        • Audisio R.
        • Gennari R.
        • Sunouchi K.
        • Nair H.R.
        • Sestini A.
        • Pope D.
        • et al.
        Preoperative assessment of Cancer in elderly patients: a pilot study.
        Support Cancer Ther. 2003; 1: 55-60
        • Audisio R.A.
        • Pope D.
        • Ramesh H.
        • Gennari R.
        • van Leeuwen B.
        • West C.
        • et al.
        Shall we operate? Preoperative assessment in elderly patients can help.
        Crit. Rev. Oncol. Hematol. 2008; 65: 156-163